Does profound acid inhibition improve haemostasis in peptic ulcer bleeding?
Berstad
A
A
Division of Gastroenterology, Medical Dept. A, Haukeland University Hospital, Bergen, Norway.
D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000150:complications*; D016558:Hemostasis, Endoscopic; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use*; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy* / Q000628:therapy; D013276:Stomach Ulcer / Q000150:complications*; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D009853:Omeprazole